NFE2L2 and non-small cell lung carcinoma: Liang et al. [96] discovered that PRLX93936 synergized with cisplatin-induced ferroptosis in NSCLC cells by incrementing ROS, peroxidation, and Fe2+ levels, while reducing GPX4 expression through the NRF2/KEAP1 pathway.